These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
967 related articles for article (PubMed ID: 24606535)
21. Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells. Suo A; Qian J; Zhang Y; Liu R; Xu W; Wang H Mater Sci Eng C Mater Biol Appl; 2016 May; 62():564-73. PubMed ID: 26952460 [TBL] [Abstract][Full Text] [Related]
22. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery. Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244 [TBL] [Abstract][Full Text] [Related]
23. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation. Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165 [TBL] [Abstract][Full Text] [Related]
24. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411 [TBL] [Abstract][Full Text] [Related]
25. Disulfide-cross-linked PEG-block-polypeptide nanoparticles with high drug loading content as glutathione-triggered anticancer drug nanocarriers. Chen YF; Chang CH; Lin CY; Lin LF; Yeh ML; Jan JS Colloids Surf B Biointerfaces; 2018 May; 165():172-181. PubMed ID: 29482128 [TBL] [Abstract][Full Text] [Related]
26. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects. Gao F; Li L; Liu T; Hao N; Liu H; Tan L; Li H; Huang X; Peng B; Yan C; Yang L; Wu X; Chen D; Tang F Nanoscale; 2012 Jun; 4(11):3365-72. PubMed ID: 22538830 [TBL] [Abstract][Full Text] [Related]
27. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles. Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221 [TBL] [Abstract][Full Text] [Related]
28. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777 [TBL] [Abstract][Full Text] [Related]
29. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates. Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy. Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598 [TBL] [Abstract][Full Text] [Related]
31. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy. Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147 [TBL] [Abstract][Full Text] [Related]
33. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455 [TBL] [Abstract][Full Text] [Related]
34. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo. Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029 [TBL] [Abstract][Full Text] [Related]
35. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy. Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942 [TBL] [Abstract][Full Text] [Related]
36. In situ crosslinked smart polypeptide nanoparticles for multistage responsive tumor-targeted drug delivery. Yi H; Liu P; Sheng N; Gong P; Ma Y; Cai L Nanoscale; 2016 Mar; 8(11):5985-95. PubMed ID: 26926103 [TBL] [Abstract][Full Text] [Related]
37. Doxorubicin conjugate of poly(ethylene glycol)-block-polyphosphoester for cancer therapy. Sun CY; Dou S; Du JZ; Yang XZ; Li YP; Wang J Adv Healthc Mater; 2014 Feb; 3(2):261-72. PubMed ID: 23852934 [TBL] [Abstract][Full Text] [Related]
38. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery. Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060 [TBL] [Abstract][Full Text] [Related]
39. Structure-directing star-shaped block copolymers: supramolecular vesicles for the delivery of anticancer drugs. Yang C; Liu SQ; Venkataraman S; Gao SJ; Ke X; Chia XT; Hedrick JL; Yang YY J Control Release; 2015 Jun; 208():93-105. PubMed ID: 25813888 [TBL] [Abstract][Full Text] [Related]
40. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study. Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]